# EBUS-TBNA Versus EBUS-TBNB

> **NCT01467635** · NA · WITHDRAWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust**

## Conditions studied

- Mediastinal Lymphadenopathy
- Hilar Lymphadenopathy
- Carcinoma
- Lymphoma
- Sarcoidosis
- Mycobacterial Disease

## Interventions

- **DEVICE:** Endobronchial ultrasound guided lymph node sampling

## Key facts

- **NCT ID:** NCT01467635
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Manufacturer did not develop and deliver the necessary biopsy forceps needles in time
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467635, "EBUS-TBNA Versus EBUS-TBNB". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01467635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*